<code id='4B0382F086'></code><style id='4B0382F086'></style>
    • <acronym id='4B0382F086'></acronym>
      <center id='4B0382F086'><center id='4B0382F086'><tfoot id='4B0382F086'></tfoot></center><abbr id='4B0382F086'><dir id='4B0382F086'><tfoot id='4B0382F086'></tfoot><noframes id='4B0382F086'>

    • <optgroup id='4B0382F086'><strike id='4B0382F086'><sup id='4B0382F086'></sup></strike><code id='4B0382F086'></code></optgroup>
        1. <b id='4B0382F086'><label id='4B0382F086'><select id='4B0382F086'><dt id='4B0382F086'><span id='4B0382F086'></span></dt></select></label></b><u id='4B0382F086'></u>
          <i id='4B0382F086'><strike id='4B0382F086'><tt id='4B0382F086'><pre id='4B0382F086'></pre></tt></strike></i>

          focus

          focus

          author:Wikipedia    Page View:54352
          Adobe

          UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

          “Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

          advertisement

          Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Biogen nominates mother of director’s child to replace him on board
          Biogen nominates mother of director’s child to replace him on board

          StevenSenn/APBiogen,abiotechgiantplaguedbyyearsofboardroomstrife,saidlateMondaythatthelongtimeandpol

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Pioneering cancer drug will cost $475,000. Analysts call it a bargain

          VictorSeguraIbarraandRitaSerda,Ph.D.,NCI,NIHTheFoodandDrugAdministrationonWednesdayapprovedafuturist